Eli Lilly and Company
Treatment of Genital Psoriasis
Last updated:
Abstract:
Methods of treating genital psoriasis, genital pruritus and genital psoriasis sexual activity impairment with anti-IL17A antibodies, including dose regimens and pharmaceutical formulations of anti-IL17A antibodies for use in the treatment of genital psoriasis, genital pruritus and genital psoriasis sexual activity impairment.
Status:
Application
Type:
Utility
Filling date:
13 Jan 2020
Issue date:
7 May 2020